Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Elsässer, A.
Right arrow Articles by Hamm, C. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Elsässer, A.
Right arrow Articles by Hamm, C. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Percutaneous coronary intervention guidelines: new aspects for the interventional treatment of acute coronary syndromes

Albrecht Elsässer and Christian W. Hamm*

Kerckhoff Heart Center, Bad Nauheim, Germany

* Corresponding author. Tel: +49 6032 9962202; fax: +49 6032 9962298. E-mail address: c.hamm{at}kerckhoff-klinik.de

In March 2005, the European Society of Cardiology (ESC) guidelines on percutaneous coronary intervention (PCI) were published, in which the management of patients with acute coronary syndromes (ACSs) was presented in detail for the interventional cardiologist. These guidelines supplement previous guidelines from the ESC on ACS with and without ST-elevation. Patients presenting with non-ST-segment elevation ACS should be treated according to the risk of progressing to myocardial infarction (MI) or death. Immediate (<2.5 h) or early (<48 h) coronary angiography and PCI are advised, particularly in patients with elevated troponin levels or diabetes mellitus. Coronary intervention in high-risk patients should be performed with triple antiplatelet therapy (aspirin, clopidogrel, and glycoprotein IIb/IIIa inhibitors). In patients with ST-segment elevation MI, primary PCI is the preferred treatment option, particularly >3 h after onset of clinical symptoms. Adjunctive therapy should include abciximab. Patients treated with thrombolysis should undergo invasive evaluation within 24 h. If this cannot be achieved, ischaemia-driven angiography is recommended.

Key Words: Acute coronary syndrome • Percutaneous coronary intervention


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.